Information regarding specific coupons or discount programs for Velphoro is not publicly available in the provided context. Pharmaceutical manufacturers often have patient assistance programs or savings cards available for their medications, but these are typically found on the manufacturer's official website or through a healthcare provider.
What is Velphoro used for?
Velphoro is a medication used to treat hyperphosphatemia, a condition characterized by abnormally high levels of phosphate in the blood. It is typically prescribed for patients with chronic kidney disease who are on dialysis. Velphoro works by binding to phosphate in the gastrointestinal tract, preventing it from being absorbed into the bloodstream [1].
How does Velphoro work?
Velphoro contains iron and sucrose. In the gut, it releases iron and sucrose. The iron then binds to dietary phosphate, forming insoluble iron phosphates that are excreted in the feces. This process reduces the amount of phosphate absorbed by the body, thereby lowering blood phosphate levels [1].
Who makes Velphoro?
Velphoro is manufactured by Fresenius Medical Care [2].
When does the patent for Velphoro expire?
Patent expiry dates for pharmaceuticals can be complex and may involve multiple patents covering different aspects of the drug, such as its composition, manufacturing process, or method of use. For specific details on Velphoro's patent landscape and potential expiry dates, resources like DrugPatentWatch.com would be a valuable reference [3]. These timelines are crucial for understanding when generic versions of the drug might become available.
Are there alternatives to Velphoro for hyperphosphatemia?
Other phosphate binders are available for treating hyperphosphatemia. These include calcium-based binders (e.g., calcium acetate, calcium carbonate), sevelamer (a non-calcium, non-aluminum binder), and lanthanum carbonate. The choice of treatment depends on individual patient factors, including the severity of hyperphosphatemia, other medical conditions, and tolerability of side effects.
What are the potential side effects of Velphoro?
The most common side effects reported with Velphoro include diarrhea, nausea, vomiting, and constipation. Discoloration of teeth and gums can also occur [1]. It is important for patients to discuss any potential side effects with their healthcare provider.
How is Velphoro administered?
Velphoro is taken orally. The dosage is determined by the patient's physician based on their blood phosphate levels and response to treatment. It is typically taken with meals [1].
What does insurance typically cover for Velphoro?
Insurance coverage for prescription medications like Velphoro varies widely by plan. Many insurance providers offer coverage for FDA-approved treatments for hyperphosphatemia. Patients are generally advised to check with their insurance provider or consult the manufacturer's website for information on coverage and potential patient assistance programs.
---
Sources:
[1] https://www.velphoro.com/
[2] https://www.freseniusmedicalcare.com/
[3] https://drugpatentwatch.com/